ATE106871T1 - Pyridinderivate und verfahren zu ihrer synthese. - Google Patents

Pyridinderivate und verfahren zu ihrer synthese.

Info

Publication number
ATE106871T1
ATE106871T1 AT91301571T AT91301571T ATE106871T1 AT E106871 T1 ATE106871 T1 AT E106871T1 AT 91301571 T AT91301571 T AT 91301571T AT 91301571 T AT91301571 T AT 91301571T AT E106871 T1 ATE106871 T1 AT E106871T1
Authority
AT
Austria
Prior art keywords
processes
synthesis
pyride
derivatives
pyride derivatives
Prior art date
Application number
AT91301571T
Other languages
English (en)
Inventor
Charles W Murtiashaw
George J Quallich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE106871T1 publication Critical patent/ATE106871T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT91301571T 1990-03-07 1991-02-27 Pyridinderivate und verfahren zu ihrer synthese. ATE106871T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/490,906 US5068333A (en) 1990-03-07 1990-03-07 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Publications (1)

Publication Number Publication Date
ATE106871T1 true ATE106871T1 (de) 1994-06-15

Family

ID=23949994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91301571T ATE106871T1 (de) 1990-03-07 1991-02-27 Pyridinderivate und verfahren zu ihrer synthese.

Country Status (10)

Country Link
US (2) US5068333A (de)
EP (1) EP0445950B1 (de)
JP (1) JPH0586031A (de)
AT (1) ATE106871T1 (de)
CA (1) CA2037590A1 (de)
DE (1) DE69102315T2 (de)
ES (1) ES2055529T3 (de)
FI (1) FI911124L (de)
IE (1) IE910740A1 (de)
PT (1) PT96948A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11257361A (ja) 1998-01-08 1999-09-21 Nippon Seiko Kk 転がり軸受の密封装置
CN103664765A (zh) * 2013-12-06 2014-03-26 常熟市联创化学有限公司 一种2-氨基-3-溴吡啶的制备方法
CN105061300B (zh) * 2015-08-31 2018-02-16 南京红太阳生物化学有限责任公司 一种氯代吡啶及其衍生物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4287347A (en) * 1980-05-12 1981-09-01 Ciba-Geigy Corporation Process for producing 2,3,5-trichloropyridine
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
CA1217774A (en) * 1983-09-06 1987-02-10 Richard L. Burson Halopyridines
FI901087A0 (fi) * 1987-09-04 1990-03-02 Pfizer Azolidindionderivat.
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives

Also Published As

Publication number Publication date
CA2037590A1 (en) 1991-09-08
FI911124A7 (fi) 1991-09-08
ES2055529T3 (es) 1994-08-16
US5336771A (en) 1994-08-09
EP0445950A1 (de) 1991-09-11
IE910740A1 (en) 1991-09-11
FI911124A0 (fi) 1991-03-06
US5068333A (en) 1991-11-26
PT96948A (pt) 1991-10-31
DE69102315D1 (de) 1994-07-14
EP0445950B1 (de) 1994-06-08
JPH0586031A (ja) 1993-04-06
FI911124L (fi) 1991-09-08
DE69102315T2 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE162790T1 (de) Verbesserte methode der synthese
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
FR2645533B1 (fr) Procede de synthese de sulfonylimidures
ATE58534T1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
NO996324L (no) Fremgangsmåte for fremstilling av mellomprodukter i syntese av benzopyranforbindelser
ATE104296T1 (de) Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung.
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
ATE181049T1 (de) Synthese von bisindolylmaleimiden
MA21148A1 (fr) Procede de preparation de compose b-lactamique et intermediaires pour sa synthese .
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
ATE106871T1 (de) Pyridinderivate und verfahren zu ihrer synthese.
DE69023532D1 (de) Verfahren zur Synthese von Acylamino-Organosilicium-Verbindungen.
DE69011719D1 (de) Verfahren zur Synthese von Acylamino-organosilicium-Verbindungen.
ES2157323T3 (es) Procedimiento mejorado para sintetizar productos intermedios carbapenemicos.
DE69737376D1 (de) Verfahren zur Synthese einer Oxonolverbindung
FR2609463B1 (fr) Synthese des perfluoroalkyl-2 ethanethiols
FI951350A0 (fi) Menetelmä substituoitujen imisadsoliyhdisteiden käyttökelpoisten välituotteiden syntetisoimiseksi
DE69006888D1 (de) Verfahren zur Synthese von Acylamino-Organosilicon-Verbindungen.
DE59206765D1 (de) Verfahren zur enzymatischen Synthese von 2-Desoxy-beta-D-galactosiden
DE59009951D1 (de) Verfahren zur Herstellung von Zwischenprodukten und zur Synthese von N-(2-Hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidine.
MX9305467A (es) Compuestos intermedios, quirales, de quinolona y procedimiento para su preparacion.
PT86821A (pt) Process for the preparation of novel tetrazole intermediates useful for the preparation of antihypercholesterolemic compounds
FI934468A7 (fi) Bentseeniboorihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö synteesin välituotteina
DZ1704A1 (fr) Dérivés de la n-(phényléthyl-b-ol) amine ainsi queleur procédé de préparation.
DE69229017D1 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee